GlassScriptPhysician profile
Laura Darnell
NPI 1457654451
$729.63
in general payments reported to CMS, 2019-2025
19 companies · $20.50 in 2025
The $20.50 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $142 · 2022: $34.97 · 2023: $164 · 2024: $367 · 2025: $20.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $121.46 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.94 | 2023 | Lifevest |
| Lilly USA, LLC | $95.88 | 2021-2024 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $55.30 | 2021-2024 | Airsupra |
| Merck Sharp & Dohme LLC | $45.88 | 2021-2024 | Gardasil, Capvaxive, Gardasil 9 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.65 | 2021-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $39.36 | 2022-2023 | |
| Astellas Pharma US INC | $35.36 | 2024 | Veozah |
| Antares Pharma, INC. | $28.59 | 2024 | Xyosted |
| Abbott Laboratories | $27.67 | 2023 | Assurity |
| Abbvie INC. | $22.21 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $17.75 | 2024 | Rexulti |
| Idorsia Pharmaceuticals US INC | $17.00 | 2024 | Quviviq |
| Pfizer INC. | $16.68 | 2022 | |
| Sumitomo Pharma America, INC. | $16.58 | 2024 | Gemtesa |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, INC. | $16.49 | 2024 | Rexulti |
| Glaxosmithkline, LLC. | $13.66 | 2021 | |
| Exact Sciences Corporation | $13.58 | 2024 | Cologuard Collection Kit |
| Genentech USA, INC. | $5.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Darnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.